Pediatric patients often present unique challenges in pharmacotherapy due to differences in drug metabolism, growth, and development compared to adults. Genetic variations can influence these factors, making pharmacogenomics particularly relevant. PharmGKB provides critical information that can help pediatricians tailor medications based on a child’s genetic makeup, thereby improving the efficacy and safety of treatments.